[1]  Lv, Z., Liu, M., Shen, J., Xiang, D., Ma, Y*, & Ji, Y. (2018). Association of serum interleukin‑10, interleukin‑17A and transforming growth factor‑α levels with human benign and malignant breast diseases. Experimental and therapeutic medicine,15(6), 5475-5480.（第一通讯作者）

[2]  Liu, M., Zhao, X., Ma, Y., Zhou, Y., Deng, M., & Ma, Y. (2018). Transcription factor c‐Maf is essential for IL‐10 gene expression in B cells. Scandinavian journal of immunology,88(3), e12701.

[3]    Ma YF^#, Chen C^#, Li D^#, Liu M; Lv ZW; Ji Y; Xu J*. Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer. Oncotarget. 2017 8(5):7614-7624.

[4]    Ma YF，Ren Y, Dai ZJ, Wu CJ, Ji YH, Xu JR*.IL-6, IL-8, and TNF-a levels correlate with disease stage in breast cancer patients. Adv Clin Exp Med 2017

    26(3):421–426

[5]    Ma YF^#, Ren Y^#, Wu CJ^#, Zhao XH, Xu H, Wu DZ, Xu J, Zhang XL, Ji Y*. Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer. Mol Immunol 2016, 75, 11-20.

[6]    Dai ZJ^#*, Liu XH^#, Ma YF^#, et al. Association between Single Nucleotide Polymorphisms in DNA polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study. Medicine (Baltimore). 2016. 95(2): e2466. (共同第一作者)

[7]    Wang M^#, Wang XJ^#, Ma YF^#, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ*:.PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk. Ther Clin Risk Manag 2015, 11, 237-45. (共同第一作者)

[8]      Dai ZJ^#*, Wang BF^#, Ma YF^#, Kang HF, Diao Y, Zhao Y, Lin S, Lv Y, Wang M, Wang XJ: Current evidence on the relationship between rs1256049 polymorphism in estrogen receptor-beta gene and cancer risk. Int J Clin Exp Med 2014, 7, 5031-40.(共同第一作者)

[9]    Ding C^#, Ma Y^#, Chen X, Liu M, Cai Y, Hu X, Xiang D, Nath S, Zhang HG, Ye H, Powell D, Yan J* Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance. Nat Commun 2013, 4, 2813. (共同第一作者)

[10]  Ma Y^#, Xiang D^#, Sun J, Ding C, Liu M, Hu X, Li G, Kloecker G, Zhang HG, Yan J*. Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development. J Immunol 2013, 190, 5588-99.

[11]  Ma Y^#, Chen HD^#, Wang Y^#, Wang Q, Li Y, Zhao Y, Zhang XL*:Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection. Microbes Infect 2011, 13, 1099-110.

[12]  Ma Y, Chen H, Wang Q, Luo F, Yan J, Zhang XL*.IL-24 protects against Salmonella typhimurium infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells. Eur J Immunol 2009, 39, 3357-68.

[13]  Wang QL^#, Pan Q^#, Ma Y^#, Wang K, Sun P, Liu S, Zhang XL*: An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine 2009, 27, 6712-22. (共同第一作者)

[14]    Liu M, Luo F, Ding C, Albeituni S, Hu X, Ma Y, Cai Y, McNally L, Sanders MA, Jain D, Kloecker G, Bousamra M, Zhang HG, Higashi RM, Lane AN, Fan TW, Yan J .Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype. J Immunol 2015; 195:5055-65;

[15]    Gunn L, Ding C, Liu M, Ma Y, Qi C, Cai Y, Hu X, Aggarwal D, Zhang HG, Yan J: Opposing roles for complement component C5a in tumor progression and the tumor microenvironment. J Immunol 2012, 189, 2985-94.

[16]    Cai Y, Xue F, Fleming C, Yang J, Ding C, Ma Y, Liu M, Zhang HG, Zheng J, Xiong N, Yan J*: Differential developmental requirement and peripheral regulation for dermal Vgamma4 and Vgamma6T17 cells in health and inflammation. Nat Commun 2014, 5, 3986.

[17]    Zhao W, Dong Y, Wu C, Ma Y, Jin Y, Ji Y*: MiR-21 overexpression improves osteoporosis by targeting RECK. Mol Cell Biochem 2015, 405, 125-33.

[18]    Zhao W, Wu C, Dong Y, Ma Y, Jin Y, Ji Y*: MicroRNA-24 Regulates Osteogenic Differentiation via Targeting T-Cell Factor-1. Int J Mol Sci 2015, 16, 11699-712.

[19]    Zhao W, Dong Y, Wu C, Ma Y, Jin Y, Ji Y*. TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models. Exp Cell Res. 2016. 340(1): 132-8.